Venture Capital 102 Featuring Frank David, MD, PhD, Founder and Managing Director at Pharmagellan [Harvard Biotech Club]


Wednesday, February 14, 2018, 5:00pm to 6:30pm


Harvard Medical School, Cannon Room, Building C
What is venture capital in the life sciences? Join us for a discussion of valuations and finance in biotech followed by a Q&A session. Biotech forecasts and valuation models are essential when evaluating publicly traded biotech companies, licensing deals, venture investments, and even your own biotech startup!
Dinner will be provided, please click here to RSVP.
For questions, please email